Lanutan, Cedrick Liam A.

HRN: 26-06-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/26/2026
05/03/2026
IV
435
Q6
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: